Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Advisory

Bicara Therapeutics to Present at Upcoming November Investor Conferences


Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to modulate the tumor microenvironment to elicit a potent and durable anti-tumor response, today announced that company leadership will present at two upcoming investor conferences in November:

About Bicara Therapeutics:

Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company's bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Bicara's lead product candidate, BCA101, is a first-in-class EGFR/TGF-?-trap bifunctional antibody in clinical development for multiple tumor types. For more information, please visit www.bicara.com or follow us on LinkedIn or X.


These press releases may also interest you

at 17:45
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...

at 17:44
Non-cash impairment of SEK 11.4 billion to be recorded in the second quarter 2024, relating to the impairment of intangibles mainly attributed to the Vonage acquisitionReflects lower anticipated market growth in some of Vonage's current portfolioThe...

at 17:40
Bayen Group, a leading provider of IT solutions and services, has been nominated for the prestigious Southern California Minority Supplier Development Council (SCMSDC) Supplier of the Year award by Northrop Grumman, a global aerospace and defense...

at 17:25
The global secondary tickets market size is estimated to grow by USD 132.1 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 34.25% during the forecast period. Rising popularity of sports events is driving...

at 17:25
The global electric car rental market size is estimated to grow by USD 18.00 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.68% during the forecast period. Increasing demand for rental cars due...

at 17:20
The global supercomputer market size is estimated to grow by USD 33.45 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 28.54% during the forecast period. Commercial customers increasingly adopting...



News published on and distributed by: